993 related articles for article (PubMed ID: 11282684)
1. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
[TBL] [Abstract][Full Text] [Related]
2. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
3. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
[TBL] [Abstract][Full Text] [Related]
4. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
Pickar D; Bartko JJ
Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
[TBL] [Abstract][Full Text] [Related]
6. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
Potkin SG; Jin Y; Bunney BG; Costa J; Gulasekaram B
Am J Psychiatry; 1999 Jan; 156(1):145-7. PubMed ID: 9892314
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
Taylor DM; Smith L
Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
[TBL] [Abstract][Full Text] [Related]
8. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
[TBL] [Abstract][Full Text] [Related]
9. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes.
Arango C; Breier A; McMahon R; Carpenter WT; Buchanan RW
Am J Psychiatry; 2003 Aug; 160(8):1421-7. PubMed ID: 12900303
[TBL] [Abstract][Full Text] [Related]
10. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ;
Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663
[TBL] [Abstract][Full Text] [Related]
11. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
Lieberman JA; Safferman AZ; Pollack S; Szymanski S; Johns C; Howard A; Kronig M; Bookstein P; Kane JM
Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
[TBL] [Abstract][Full Text] [Related]
13. The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia.
Hofer A; Hummer M; Kemmler G; Kurz M; Kurzthaler I; Fleischhacker WW
Int J Neuropsychopharmacol; 2003 Sep; 6(3):201-6. PubMed ID: 12974985
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
[TBL] [Abstract][Full Text] [Related]
15. Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.
Leucht S; Pitschel-Walz G; Engel RR; Kissling W
Am J Psychiatry; 2002 Feb; 159(2):180-90. PubMed ID: 11823257
[TBL] [Abstract][Full Text] [Related]
16. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.
Rosenheck RA; Leslie DL; Sindelar J; Miller EA; Lin H; Stroup TS; McEvoy J; Davis SM; Keefe RS; Swartz M; Perkins DO; Hsiao JK; Lieberman J;
Am J Psychiatry; 2006 Dec; 163(12):2080-9. PubMed ID: 17151158
[TBL] [Abstract][Full Text] [Related]
18. Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials.
Tuunainen A; Wahlbeck K; Gilbody S
Schizophr Res; 2002 Jul; 56(1-2):1-10. PubMed ID: 12084413
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.
Leucht S; Komossa K; Rummel-Kluge C; Corves C; Hunger H; Schmid F; Asenjo Lobos C; Schwarz S; Davis JM
Am J Psychiatry; 2009 Feb; 166(2):152-63. PubMed ID: 19015230
[TBL] [Abstract][Full Text] [Related]
20. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
